 | • レポートコード：PMR2009002 • 出版社/出版日：Persistence Market Research / 2020年7月20日 • レポート形態：英文、PDF、251ページ • 納品方法：Eメール • 産業分類：バイオ |
| Individual User（1名用） | ￥715,400 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,109,600 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,547,600 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、哺乳動物セルバンクの世界市場を徹底調査するとともに、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、市場状況、価格分析・予測、細胞別（CHO、BHK、NS0、YB2/0・P2/0、HEK293・デリバティブ）分析、技術別（一過性発現プラットフォーム、誘導型発現プラットフォーム、安定発現プラットフォーム）分析、セルバンク別（マスターセルバンク（MCB）、ワーキングセルバンク（WCB）、エンドオブプロダクションセルバンク（Epos）、研究・開発セルバンク（R＆D CB））分析、エンドユーザー別（学術研究所、バイオ製薬会社、受託研究機関）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを明らかに致します。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・市場状況 ・価格分析・予測 ・哺乳動物セルバンクの世界市場規模：細胞別（CHO、BHK、NS0、YB2/0・P2/0、HEK293・デリバティブ） ・哺乳動物セルバンクの世界市場規模：技術別（一過性発現プラットフォーム、誘導型発現プラットフォーム、安定発現プラットフォーム） ・哺乳動物セルバンクの世界市場規模：セルバンク別（マスターセルバンク（MCB）、ワーキングセルバンク（WCB）、エンドオブプロダクションセルバンク（Epos）、研究・開発セルバンク（R＆D CB）） ・哺乳動物セルバンクの世界市場規模：エンドユーザー別（学術研究所、バイオ製薬会社、受託研究機関） ・哺乳動物セルバンクの世界市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Mammalian Cell Banking Market – Scope of the Report
The latest publication by Persistence Market Research (PMR) on the global mammalian cell banking market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global mammalian cell banking market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the mammalian cell banking market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for successful growth of the mammalian cell banking market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR). This research study can support readers to know the demand for mammalian cell banking and quantitative development opportunities during the study period.
The research is beneficial for shareholders in the mammalian cell banking market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the mammalian cell banking market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the mammalian cell banking market, industry experts, investors, researchers, and reporters, as well as mammalian cell banking business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the mammalian cell banking market are also included in the current study. Depending on potential developments in the mammalian cell banking market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this mammalian cell banking market report, minor companies and new entrants in the mammalian cell banking industry can be aided in making suitable company choices to achieve traction in the market.
Key Questions Answered in PMR’s Mammalian Cell Banking Market Report
Which regions will continue to remain the most profitable regional markets for mammalian cell banking market players?
Which factors will induce a change in the demand for mammalian cell banking during the assessment period?
How will changing trends impact the mammalian cell banking market?
How can market players capture the low-hanging opportunities in the mammalian cell banking in developed regions?
What are the winning strategies of stakeholders in the mammalian cell banking market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the mammalian cell banking market?
What are the developmental trends in the mammalian cell banking sectors that will impact the market?
How can businesses in the mammalian cell banking market avail the growth opportunities in developed and emerging sectors?
Mammalian Cell Banking Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the mammalian cell banking market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of mammalian cell banking market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the mammalian cell banking market, and makes PMR’s projections on the growth prospects of the mammalian cell banking market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Service Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Outlook
4.1.3. Global Banking Outsourcing Market Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. Technology Development
4.2.2. End User Demand
4.2.3. Regulatory Imposition
4.2.4. Per Cell Bank Development Spending
4.2.5. Technology Shortcomings
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. COVID19 Crisis Analysis
4.4.1. Current COVID19 Statistics and Probable Future Impact
4.4.2. Current GDP Projection and Probable Impact
4.4.3. Current Economic Projection as compared to 2008 Economic analysis
4.4.4. COVID19 and Impact Analysis
4.4.4.1. Revenue By Service
4.4.4.2. Revenue By Country
4.4.5. 2020 Market Scenario
4.4.6. Quarter by Quarter Forecast
4.4.7. Projected recovery Quarter
4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
5. Market Context
5.1. GMP Guideline for Mammalian Cell Bank Development & Manufacturing
5.2. Regulatory Scenario
5.3. Value Chain Analysis
5.4. Key Strategies Adopted By Cell Bank Service Providers
5.5. Technology Adoption Analysis
6. Global Mammalian Cell Banking Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2020-2030
7. Global Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030, By Cell
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Cell, 2015–2019
7.3. Current and Future Market Size (US$ Mn) and Forecast By Cell, 2020-2030
7.3.1. CHO
7.3.2. BHK
7.3.3. NS0
7.3.4. YB2/0 & P2/0
7.3.5. HEK293 & Derivatives
7.3.6. HELA
7.4. Market Attractiveness Analysis By Cell
8. Global Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030
8.3.1. Transient Expression Platform
8.3.2. Inducible Expression Platform
8.3.3. Stable Expression Platform
8.4. Market Attractiveness Analysis By Technology
9. Global Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Cell Bank, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell Bank, 2020-2030
9.3.1. Master Cell Bank (MCB)
9.3.2. Working Cell Bank (WCB)
9.3.3. End of Production Cell Bank (Epos)
9.3.4. Research & Development Cell Bank (R&D CB)
9.4. Market Attractiveness Analysis By Cell Bank
10. Global Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
10.3.1. Academic & Research Laboratories
10.3.2. Biopharmaceutical companies
10.3.3. Contract Research Organization
10.4. Market Attractiveness Analysis By End User
11. Global Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Region, 2015–2019
11.3. Current and Future Market Size (US$ Mn) and Forecast By Region, 2020-2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
12.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Cell
12.3.3. By Technology
12.3.4. By Cell Bank
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Cell
13.3.3. By Technology
13.3.4. By Cell Bank
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Cell
14.3.3. By Technology
14.3.4. By Cell Bank
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Cell
15.3.3. By Technology
15.3.4. By Cell Bank
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Cell
16.3.3. By Technology
16.3.4. By Cell Bank
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
17.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Cell
17.3.3. By Technology
17.3.4. By Cell Bank
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2019
18.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Cell
18.3.3. By Technology
18.3.4. By Cell Bank
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Emerging & Key Countries Mammalian Cell Banking Market Analysis 2015-2019 and Forecast 2020-2030
19.1. U.S. Mammalian Cell Banking Market Analysis
19.1.1. By Cell
19.1.2. By Technology
19.1.3. By Cell Bank
19.1.4. By End User
19.2. Canada Mammalian Cell Banking Market Analysis
19.2.1. By Cell
19.2.2. By Technology
19.2.3. By Cell Bank
19.2.4. By End User
19.3. Mexico Mammalian Cell Banking Market Analysis
19.3.1. By Cell
19.3.2. By Technology
19.3.3. By Cell Bank
19.3.4. By End User
19.4. Brazil Mammalian Cell Banking Market Analysis
19.4.1. By Cell
19.4.2. By Technology
19.4.3. By Cell Bank
19.4.4. By End User
19.5. U.K. Mammalian Cell Banking Market Analysis
19.5.1. By Cell
19.5.2. By Technology
19.5.3. By Cell Bank
19.5.4. By End User
19.6. Germany Mammalian Cell Banking Market Analysis
19.6.1. By Cell
19.6.2. By Technology
19.6.3. By Cell Bank
19.6.4. By End User
19.7. France Mammalian Cell Banking Market Analysis
19.7.1. By Cell
19.7.2. By Technology
19.7.3. By Cell Bank
19.7.4. By End User
19.8. Italy Mammalian Cell Banking Market Analysis
19.8.1. By Cell
19.8.2. By Technology
19.8.3. By Cell Bank
19.8.4. By End User
19.9. Spain Mammalian Cell Banking Market Analysis
19.9.1. By Cell
19.9.2. By Technology
19.9.3. By Cell Bank
19.9.4. By End User
19.10. BENELUX Mammalian Cell Banking Market Analysis
19.10.1. By Cell
19.10.2. By Technology
19.10.3. By Cell Bank
19.10.4. By End User
19.11. Russia Mammalian Cell Banking Market Analysis
19.11.1. By Cell
19.11.2. By Technology
19.11.3. By Cell Bank
19.11.4. By End User
19.12. China Mammalian Cell Banking Market Analysis
19.12.1. By Cell
19.12.2. By Technology
19.12.3. By Cell Bank
19.12.4. By End User
19.13. India Mammalian Cell Banking Market Analysis
19.13.1. By Cell
19.13.2. By Technology
19.13.3. By Cell Bank
19.13.4. By End User
19.14. Japan Mammalian Cell Banking Market Analysis
19.14.1. By Cell
19.14.2. By Technology
19.14.3. By Cell Bank
19.14.4. By End User
19.15. South Korea Mammalian Cell Banking Market Analysis
19.15.1. By Cell
19.15.2. By Technology
19.15.3. By Cell Bank
19.15.4. By End User
19.16. ASEAN Mammalian Cell Banking Market Analysis
19.16.1. By Cell
19.16.2. By Technology
19.16.3. By Cell Bank
19.16.4. By End User
19.17. Australia Mammalian Cell Banking Market Analysis
19.17.1. By Cell
19.17.2. By Technology
19.17.3. By Cell Bank
19.17.4. By End User
19.18. New Zealand Mammalian Cell Banking Market Analysis
19.18.1. By Cell
19.18.2. By Technology
19.18.3. By Cell Bank
19.18.4. By End User
19.19. GCC Countries Mammalian Cell Banking Market Analysis
19.19.1. By Cell
19.19.2. By Technology
19.19.3. By Cell Bank
19.19.4. By End User
19.20. Turkey Mammalian Cell Banking Market Analysis
19.20.1. By Cell
19.20.2. By Technology
19.20.3. By Cell Bank
19.20.4. By End User
19.21. South Africa Mammalian Cell Banking Market Analysis
19.21.1. By Cell
19.21.2. By Technology
19.21.3. By Cell Bank
19.21.4. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint by Players
20.3.2. Service Foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive (Tentative List)
21.3.1. Sartorius Stedim BioOutsource Limited.
21.3.1.1. Overview
21.3.1.2. Service Portfolio
21.3.1.3. Profitability by Market Segments(Service/Channel/Country)
21.3.1.4. Service Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Service Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Charles River Laboratories.
21.3.2.1. Overview
21.3.2.2. Service Portfolio
21.3.2.3. Profitability by Market Segments(Service/Channel/Country)
21.3.2.4. Service Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Service Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Eurofins DiscoverX Corporation
21.3.3.1. Overview
21.3.3.2. Service Portfolio
21.3.3.3. Profitability by Market Segments(Service/Channel/Country)
21.3.3.4. Service Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Service Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Merck KGaA
21.3.4.1. Overview
21.3.4.2. Service Portfolio
21.3.4.3. Profitability by Market Segments(Service/Channel/Country)
21.3.4.4. Service Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Service Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Lonza Group Ltd
21.3.5.1. Overview
21.3.5.2. Service Portfolio
21.3.5.3. Profitability by Market Segments(Service/Channel/Country)
21.3.5.4. Service Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Service Strategy
21.3.5.5.3. Channel Strategy
21.3.6. VIRUSURE
21.3.6.1. Overview
21.3.6.2. Service Portfolio
21.3.6.3. Profitability by Market Segments(Service/Channel/Country)
21.3.6.4. Service Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Service Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Altogen Labs
21.3.7.1. Overview
21.3.7.2. Service Portfolio
21.3.7.3. Profitability by Market Segments(Service/Channel/Country)
21.3.7.4. Service Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Service Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Abzena Ltd
21.3.8.1. Overview
21.3.8.2. Service Portfolio
21.3.8.3. Profitability by Market Segments(Service/Channel/Country)
21.3.8.4. Service Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Service Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Northway Biotechpharma
21.3.9.1. Overview
21.3.9.2. Service Portfolio
21.3.9.3. Profitability by Market Segments(Service/Channel/Country)
21.3.9.4. Service Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Service Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Selexis SA
21.3.10.1. Overview
21.3.10.2. Service Portfolio
21.3.10.3. Profitability by Market Segments(Service/Channel/Country)
21.3.10.4. Service Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Service Strategy
21.3.10.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
List Of Table:Table 1: Global Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 2: Global Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 3: Global Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 4: Global Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 5: Global Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 6: North America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 7: North America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 8: North America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 9: North America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 10: North America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 11: Latin America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 12: Latin America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 13: Latin America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 14: Latin America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 15: Latin America Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 16: Europe Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 17: Europe Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 18: Europe Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 19: Europe Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 20: Europe Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 21: South Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 22: South Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 23: South Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 24: South Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 25: South Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 26: East Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 27: East Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 28: East Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 29: East Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 30: East Asia Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 31: Oceania Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 32: Oceania Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 33: Oceania Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 34: Oceania Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 35: Oceania Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 36: Middle East and Africa Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Type
Table 37: Middle East and Africa Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Technology
Table 38: Middle East and Africa Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Cell Bank
Table 39: Middle East and Africa Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 40: Middle East and Africa Mammalian Cell Banking Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country